Communique for the permanent re-instatement of telehealth phone consultations
COSA guidelines for fertility preservation for people with cancer
The COSA Fertility Preservation Guidelines Working Group has developed these guidelines to assist health professionals discuss and manage fertility preservation for people with cancer in Australia.
COSA Annual Report 2021
Medical Oncology Group of Australia Position Statement on COVID-19 vaccination in patients with solid tumours
Medical Oncology Group of Australia Position Statement on COVID-19 vaccination in patients with solid tumours (version 9 published 17 October 2021)
This position statement has been developed for cancer clinicians and other healthcare professionals caring for people with cancer. The COVID-19 pandemic is constantly evolving and the position statement may be updated with emergence of new evidence. Clinicians should remain cognisant that data is rapidly changing around current vaccines and newer agents, both in terms of positive and negative effects. This statement has been endorsed by COSA.
eviQ provides protocols and guidelines for Indication for Genetic Testing and the Management of Familiar Cancer Syndromes
Hepatocellular carcinoma (HCC) Consensus Statement
Hepatocellular carcinoma (HCC) Consensus Statement (published December 2020)
This consensus statement is applicable to specialists, general medical practitioners, nurses, health coordinators and administrators involved in the care of adult patients with hepatocellular carcinoma (HCC). The Australian recommendations for the management of hepatocellular carcinoma were produced by the Gastroenterological Society of Australia (GESA) and developed by more than sixty expert clinicians with the principle aim of improving the standard of care provided to patients suffering with this condition in Australia. The recommendations have been endorsed by COSA and other organisations listed on the website.
Gastrointestinal Cancer Group Chair